Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 23'rd Apr 2025
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bausch Health Learns Icahn Has 34% Economic Interest in Shares
09:33am, Tuesday, 22'nd Apr 2025
Activist investor Carl Icahn has tightened his hold on pharmaceutical company Bausch Health.
Bausch Health says Carl Icahn has exposure to about 34% of company's shares
08:54am, Tuesday, 22'nd Apr 2025
Billionaire Carl Icahn has a total economic exposure of about 34% to Bausch Health's common shares, the healthcare firm said in a filing on Tuesday.
Bausch Health Announces Filing of Supplement to Proxy Statement
07:25am, Tuesday, 22'nd Apr 2025
Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Shares LAVAL, QC / ACCESS Newswire / April 22, 2025
Bausch (BHC) Moves 13.3% Higher: Will This Strength Last?
11:25am, Monday, 21'st Apr 2025
Bausch (BHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
03:40pm, Thursday, 17'th Apr 2025
LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today
Bausch Health Announces Adoption of Shareholder Rights Plan
04:30pm, Monday, 14'th Apr 2025
LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approve
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
04:15pm, Thursday, 10'th Apr 2025
Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / Bausc
LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Ca
Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity
03:00am, Saturday, 05'th Apr 2025
One-eighth of the global population and one-fifth of U.S. adults suffer from mental health conditions, highlighting an urgent need for better psychiatric care. Bausch Health's Aplenzin shows promise f
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
08:00am, Wednesday, 02'nd Apr 2025
Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagno
Bausch + Lomb recalls some of its implantable eye lenses
08:44am, Thursday, 27'th Mar 2025
Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.
Bausch + Lomb Recalls EnVista Intraocular Lenses
07:30am, Thursday, 27'th Mar 2025
The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular lenses on its enVista platform.
Bausch Health to Announce First Quarter Results on April 30
07:00am, Thursday, 27'th Mar 2025
LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Hea
